Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-11
1997-10-14
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548127, A61K 3138, C07D28506
Patent
active
056773188
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 5401765 (1995-03-01), Lee
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5536752 (1996-07-01), Ducharme et al.
patent: 5550142 (1996-08-01), Ducharme et al.
CA 124:2020589 Synthesis . . . heterocycle. Gautheir et al., p. 997, 1996.
McKane Joseph
Merck Frosst Canada Inc.
Panzer Curtis C.
Rose David L.
LandOfFree
Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555583